thrombotic microangiopathies are a complex group of disorders that typically present with a schistocytic hemolytic anemia and associated thrombocytopenia with ensuing microvascular occlusion leading to tissue ischemia…
Introduction: Diabetic microangiopathy is distinguished by abnormal development and permeability of small blood vessels, culminating in local edema and impaired function of dependent tissues. Microcirculation…
Abstract Thrombotic microangiopathies (TMA) include a heterogeneous group of syndromes that share common pathological characteristics, or rather endothelial cellular damage and microvascular thrombosis, and a clinical…
Diabetes mellitus (DM) is notorious for causing retinal microangiopathy, but bulbar conjunctival microangiopathy (CM) mirroring the established retinal vessel changes, has also been observed. Recent studies suggest that…
causing cardiotoxicity. Other adverse effects such as nephrotic syndrome and Drug-Induced Thrombotic Microangiopathy (DITMA) have been described in the literature but are not as well identified in clinical practice…
characterized by ocular and oral dryness and a variety of other systemic manifestations. Thrombotic Microangiopathy (TMA) is rarely associated with SS. We report a case that illustrates this association
Hematopoietic Stem Cell Transplantation (HSCT) is known to cause thrombotic microangiopathy with an incidence of 7%, but the diagnosis can be delayed due to cytopenias and organ toxicity.We present
Thrombotic thrombocytopenic purpura (TTP) is defined as thrombotic microangiopathy occurring in the context of severe ADAMTS13 deficiency (<10%) which is a normal enzyme in plasma that cleaves large forms
renal AKI, Acute tubular necrosis or collapsing glomerulopathy. Renal injury due to thrombotic microangiopathy and cortical necrosis is not a common finding in COVID-19 infections. Here we are reporting
Calcineurin inhibitor induced thrombotic microangiopathy (TMA) is a serious complication in hematopoietic stem cell transplantation (HSCT). Mycophenolate mofetil (MMF) is a safe immunosuppressive drug that can be used…
Background: Thrombotic Microangiopathy (TMA) is a multi-organ dysfunction syndrome characterized by microvascular thrombosis, thrombocytopenia and hemolytic anemia with diverse etiologies ranging from primary Thrombotic…
Background: Transplant-associated thrombotic microangiopathy (TA-TMA) is considered one of the most severe complications after hematopoietic stem cell transplantation. Unfortunately, controversial approaches on TA-TMA…
thrombotic microangiopathies (TMAs), are a complex group of disorders that typically present with a schistocytes hemolytic anemia and associated thrombocytopenia with ensuing microvascular occlusion leading to tissue…
history had multiple sclerosis in treatment with interferon beta1b (IFN-1b). Case history Thrombotic microangiopathy was revealed by ADAMTS13 activity lower than 5%. Because of anemia and thrombocytopenia ... done and…
autoimmune multisystemic disease that can be present in myriad of ways. Thrombotic microangiopathy is a rare complication of SLE; even more rare if it was the initial presentation ... showed positive ASO, ANA and dsDNA…
Thrombotic Microangiopathy (TMA) is a complex medical condition characterized by the formation of blood clots in the small blood vessels throughout the body, leading to organ damage and dysfunction
findings of the post-mortem are consistent with a diagnosis of pulmonary tumour thrombotic microangiopathy (PTTM). This illustrates a rare presentation of PTTM, which is difficult to diagnose, treat
enable the microcirculation to be restored. The paper deals in details, how the diabetic microangiopathies take place and by exploiting the repository of unani drugs the haemorrheological disturbances